Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451711![]() (6-(2-amino-5-(2-fluoro-5- nitrophenyl)pyridin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451768![]() (US10710978, Compound KIN00I-305) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451719![]() (6-(2-amino-5-(2-fluoro-3- nitrophenyl)pyridin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451719![]() (6-(2-amino-5-(2-fluoro-3- nitrophenyl)pyridin-3-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451722![]() (6-(2-amino-5- (benzo[d]thiazol-7-yl)pyridin- 3-yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451724![]() (6-(2-amino-5- (benzo[b]thiophen-4- yl)pyridin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451728![]() (6-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451730![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451730![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451736![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451737![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451738![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451739![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451740![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451741![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451747![]() (6-(2-amino-5-(4- fluorobenzo[d]thiazol-7- yl)pyrid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451748![]() (N-(3-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451749![]() (6-(2-amino-5-(3-(thiazol-2- yl)phenyl)pyridin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451751![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451752![]() (4-(6-amino-5-(2-methyl-1- oxo-1,2,3,4- tetrahydroi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451753![]() (4-(6-amino-5-(4-oxo-3,4- dihydroquinazolin-7- yl)p...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451755![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451757![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451758![]() (4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451759![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451761![]() (4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451761![]() (4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451763![]() (6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451766![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451766![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451712![]() (6-(2-amino-5-(3- nitrophenyl)pyridin-3-yl)-3,4- di...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451744![]() (6-(2-amino-5-(2-fluoro-4- nitrophenyl)pyridin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451735![]() (6-(2-amino-5-(4-ethynyl-2- fluoro-5-nitrophenyl)py...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451742![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 24 (Homo sapiens (Human)) | BDBM451741![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451713![]() (6-(2-amino-5-(2- fluorophenyl)pyridin-3-yl)- 3,4-d...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451767![]() (6-(2-amino-5-(5- fluorobenzo[d]thiazol-6- yl)pyrid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 24 (Homo sapiens (Human)) | BDBM451766![]() (4-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451764![]() (6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451711![]() (6-(2-amino-5-(2-fluoro-5- nitrophenyl)pyridin-3-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451763![]() (6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451762![]() (3-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451762![]() (3-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451760![]() (5-(2-amino-5-(4- fluorobenzo[d]thiazol-7- yl)pyrid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451756![]() (N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451754![]() (7-(2-amino-5- (benzo[d]thiazol-7-yl)pyridin- 3-yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451750![]() (6-(2-amino-5-(2-methoxy-4- (thiazol-2-yl)phenyl)py...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451721![]() (3-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 3 (Homo sapiens (Human)) | BDBM451721![]() (3-(6-amino-5-(1-oxo-1,2,3,4- tetrahydroisoquinolin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase 4 (Homo sapiens (Human)) | BDBM451763![]() (6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; FONDAZIONE CENTRO SAN RAFFAELE US Patent | Assay Description Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ... | US Patent US10710978 (2020) BindingDB Entry DOI: 10.7270/Q2J67KZW | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 234 total ) | Next | Last >> |